AMLX MEXC RealStocks
Own real AMLX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 06:04:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Amylyx Pharmaceuticals, Inc. (AMLX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $26.62, with a market capitalization of $3.57B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $10.83 to $41.14. This page covers its latest market performance, valuation, price trends and company information.
$3.57B | |
$27.49 | |
$28.06 | |
$26.28 | |
$27.52 | |
1.30M | |
1.69M | |
-- | |
$41.14 | |
$10.83 | |
-- | |
2026-09-30 |
Amylyx Pharmaceuticals, Inc. (AMLX) last closed at $26.62 as of 2026-11-19 00:41:00, down 3.27% ($0.90) from the previous close of $27.52.
During the latest regular trading session, AMLX traded between $26.28 and $28.06, with a volume of 1.30M shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, Amylyx Pharmaceuticals, Inc. (AMLX) moved from $30.21 to $26.62, representing a decline of 11.90% ($3.60).
The stock traded between $26.28 and $31.88 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.51 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 52.1%
AMLX is currently trading at $26.62, placing it 52.1% of the way from its 52-week low of $10.83 to its 52-week high of $41.14. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 136 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Amylyx Pharmaceuticals, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | Mar 28, 2018 |
| Payment Date | Apr 2, 2018 |
| Dividend Per Share | $0.41965 |
Eligible investors can buy real shares of Amylyx Pharmaceuticals, Inc. (AMLX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to AMLX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between AMLX shares and USD.
AMLX Shares to USD
1.00 AMLX shares = 26.615 USD
Calculations are estimates based on the latest available price and are for reference only.